duloxetine medical valley 60 mg enterokapsel, hård
medical valley invest ab - duloxetinhydroklorid - enterokapsel, hård - 60 mg - propylparahydroxibensoat hjälpämne; metylparahydroxibensoat hjälpämne; sackaros hjälpämne; sockersfärer hjälpämne; duloxetinhydroklorid 67,22 mg aktiv substans; natriumlaurilsulfat hjälpämne
duloxetine medical valley 30 mg enterokapsel, hård
medical valley invest ab - duloxetinhydroklorid - enterokapsel, hård - 30 mg - duloxetinhydroklorid 33,61 mg aktiv substans; sockersfärer hjälpämne; natriumlaurilsulfat hjälpämne; propylparahydroxibensoat hjälpämne; metylparahydroxibensoat hjälpämne; sackaros hjälpämne
dasatinib accord
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiska medel - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiska medel - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
memantine pharmascope 10 mg filmdragerad tablett
pharmascope ltd - memantinhydroklorid - filmdragerad tablett - 10 mg - memantinhydroklorid 10 mg aktiv substans - memantin
memantine pharmascope 20 mg filmdragerad tablett
pharmascope ltd - memantinhydroklorid - filmdragerad tablett - 20 mg - memantinhydroklorid 20 mg aktiv substans - memantin
gabapentin rivopharm 600 mg filmdragerad tablett
rivopharm ltd. - gabapentin - filmdragerad tablett - 600 mg - gabapentin 600 mg aktiv substans - gabapentin
gabapentin rivopharm 800 mg filmdragerad tablett
rivopharm ltd. - gabapentin - filmdragerad tablett - 800 mg - gabapentin 800 mg aktiv substans - gabapentin
carboplatin rivopharm 10 mg/ml koncentrat till infusionsvätska, lösning
rivopharm ltd. - karboplatin - koncentrat till infusionsvätska, lösning - 10 mg/ml - mannitol hjälpämne; karboplatin 10 mg aktiv substans - karboplatin
pioglitazone rivopharm 45 mg tablett
rivopharm ltd. - pioglitazonhydroklorid - tablett - 45 mg - mannitol hjälpämne; pioglitazonhydroklorid 49,6 mg aktiv substans